Medline ® Abstract for Reference 127
of 'Chemotherapy for advanced exocrine pancreatic cancer'
Ettrich TJ, von Wichert G, Gress TM, et al. DOCOX: a phase II trial with docetaxel and oxaliplatin as a second-line systemic therapy for patients with advanced and/or metastatic adenocarcinoma of the pancreas (abstract). J Clin Oncol 31, 2013 (suppl; abstr 4034) http://meetinglibrary.asco.org/content/109000-132 (Accessed on June 11, 2013).
no abstract available